Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Ad icon
ZTE MF283U 4G Unlocked Router (Used)
ayanthamaxi
Updated:
Yesterday at 8:26 PM
ලංකාවේ හොඳම උපකාරක පන්ති සහ ගුරුවරුන් එකම තැනකින් - TopTuition.lk
dulithapathum
Updated:
Saturday at 8:07 AM
Colombo
RidhMathraa ’26 🎶✨
Tmadhusanka
Updated:
Wednesday at 11:58 PM
Ad icon
Colombo
PXN V10 Pro Direct Drive Racing Wheel (Under Warranty)
Abdur Rahman
Updated:
Wednesday at 10:23 PM
Ad icon
USDT ණය සේවාව - USDT Loan Service
පුරවැසියා
Updated:
Wednesday at 4:54 PM
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
ElaKiri Talk!
BioNTech to build mRNA manufacturing site in Singapore
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Bitter Truth" data-source="post: 26393294" data-attributes="member: 555686"><p>BERLIN (Reuters) -</p><p></p><p>BioNTech said on Monday it plans to set up a regional headquarters and build a new manufacturing site for its vaccines based on messenger RNA technology (mRNA) in Singapore, in the latest move to expand its production network.</p><p>The biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-based vaccines depending on the specific type, once it is operational in 2023.</p><p>BioNTech said its expansion plans were supported by the Singapore Economic Development Board and would increase the global supply of mRNA-based vaccines and establish a production facility in south east Asia to respond rapidly to future pandemics.</p><p></p><p>"Having multiple nodes in our production network is an important strategic step in building out our global footprint and capabilities," said Ugur Sahin, CEO and Co-founder of BioNTech.</p><p>Governments around the world are looking to build up local vaccine production to secure access to supplies after manufacturing setbacks have slowed the rollout of COVID-19 doses in some countries.</p><p>BioNTech plans to open the Singapore office in 2021 and expects the manufacturing site to be operational by 2023, creating up to 80 jobs in Singapore.</p><p>The establishment of a southeast Asia regional hub comes after BioNTech, based in Mainz, Germany, set up a U.S. headquarters in Cambridge, Massachusetts in 2020.</p><p>(Reporting by Caroline Copley; Editing by Maria Sheahan and Louise Heavens)</p><p></p><p><a href="https://finance.yahoo.com/news/biontech-build-mrna-manufacturing-singapore-055603367.html" target="_blank">https://finance.yahoo.com/news/biontech-build-mrna-manufacturing-singapore-055603367.html</a></p></blockquote><p></p>
[QUOTE="Bitter Truth, post: 26393294, member: 555686"] BERLIN (Reuters) - BioNTech said on Monday it plans to set up a regional headquarters and build a new manufacturing site for its vaccines based on messenger RNA technology (mRNA) in Singapore, in the latest move to expand its production network. The biotech company said the Singapore production facility will have an estimated annual capacity of several hundred million doses of mRNA-based vaccines depending on the specific type, once it is operational in 2023. BioNTech said its expansion plans were supported by the Singapore Economic Development Board and would increase the global supply of mRNA-based vaccines and establish a production facility in south east Asia to respond rapidly to future pandemics. "Having multiple nodes in our production network is an important strategic step in building out our global footprint and capabilities," said Ugur Sahin, CEO and Co-founder of BioNTech. Governments around the world are looking to build up local vaccine production to secure access to supplies after manufacturing setbacks have slowed the rollout of COVID-19 doses in some countries. BioNTech plans to open the Singapore office in 2021 and expects the manufacturing site to be operational by 2023, creating up to 80 jobs in Singapore. The establishment of a southeast Asia regional hub comes after BioNTech, based in Mainz, Germany, set up a U.S. headquarters in Cambridge, Massachusetts in 2020. (Reporting by Caroline Copley; Editing by Maria Sheahan and Louise Heavens) [URL]https://finance.yahoo.com/news/biontech-build-mrna-manufacturing-singapore-055603367.html[/URL] [/QUOTE]
Insert quotes…
Verification
Hath warak paha keeyada? (hatha wadikireema paha)
Post reply
Top
Bottom